HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hironobu Ihn Selected Research

integrin alphaVbeta5

8/2006Involvement of alphavbeta5 integrin in the establishment of autocrine TGF-beta signaling in dermal fibroblasts derived from localized scleroderma.
9/2005Involvement of alphavbeta5 integrin-mediated activation of latent transforming growth factor beta1 in autocrine transforming growth factor beta signaling in systemic sclerosis fibroblasts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hironobu Ihn Research Topics

Disease

44Systemic Scleroderma (Systemic Sclerosis)
12/2020 - 01/2002
43Neoplasms (Cancer)
01/2022 - 12/2007
40Melanoma (Melanoma, Malignant)
09/2021 - 04/2008
28Fibrosis (Cirrhosis)
12/2020 - 01/2002
15Psoriasis (Pustulosis Palmaris et Plantaris)
09/2020 - 09/2008
13Dermatomyositis (Dermatopolymyositis)
01/2019 - 07/2002
10Extramammary Paget Disease (Paget Disease, Extramammary)
01/2022 - 02/2015
10Hemangiosarcoma (Angiosarcoma)
10/2020 - 02/2015
9Neoplasm Metastasis (Metastasis)
07/2021 - 04/2008
8Autoimmune Diseases (Autoimmune Disease)
05/2020 - 04/2012
7Inflammation (Inflammations)
09/2021 - 12/2011
7Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2020 - 12/2007
7Localized Scleroderma (Morphea)
09/2013 - 06/2004
6Systemic Lupus Erythematosus (Libman-Sacks Disease)
08/2017 - 02/2003
5Disease Progression
08/2020 - 11/2013
5Collagen Diseases (Collagen Disease)
05/2020 - 09/2011
5Infections
05/2018 - 05/2011
4Pemphigus (Pemphigus Vulgaris)
01/2021 - 04/2009
4Psoriatic Arthritis
01/2021 - 04/2016
4Sclerosis
01/2020 - 07/2011
4Carcinogenesis
05/2019 - 12/2011
4Skin Diseases (Skin Disease)
01/2018 - 05/2006
4Cicatrix (Scar)
08/2017 - 09/2013
4Ulcer
08/2017 - 09/2013
3Onychomycosis (Tinea Unguium)
02/2021 - 10/2018
3Skin Manifestations
05/2020 - 10/2004
3Xeroderma Pigmentosum (Kaposi's Disease)
12/2018 - 03/2008
3Myasthenia Gravis
11/2018 - 07/2016
3Myositis (Idiopathic Inflammatory Myopathies)
11/2018 - 10/2012
3Dermatofibrosarcoma
04/2018 - 10/2002
3Polymyositis
07/2016 - 08/2007
3Rheumatic Diseases (Rheumatism)
10/2015 - 07/2012
3Mixed Connective Tissue Disease (MCTD)
10/2015 - 02/2003
3Wounds and Injuries (Trauma)
01/2014 - 02/2002
2Disseminated Intravascular Coagulation
06/2020 - 11/2018
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2020 - 04/2015
2Erythema
01/2020 - 08/2017
2Hypoxia (Hypoxemia)
02/2019 - 06/2014

Drug/Important Bio-Agent (IBA)

21Proteins (Proteins, Gene)FDA Link
07/2021 - 12/2003
19MicroRNAs (MicroRNA)IBA
01/2020 - 12/2010
18CollagenIBA
12/2020 - 10/2003
17Biomarkers (Surrogate Marker)IBA
06/2021 - 11/2013
15CytokinesIBA
02/2021 - 02/2004
13DNA (Deoxyribonucleic Acid)IBA
01/2022 - 10/2002
11NivolumabIBA
06/2020 - 01/2016
10AntigensIBA
02/2021 - 07/2002
10AntibodiesIBA
10/2020 - 07/2002
10Transforming Growth Factor beta (TGF-beta)IBA
08/2009 - 01/2002
9Immune Checkpoint InhibitorsIBA
09/2021 - 01/2016
9Messenger RNA (mRNA)IBA
01/2018 - 12/2010
8EnzymesIBA
07/2017 - 02/2003
7Pharmaceutical PreparationsIBA
02/2021 - 01/2014
7Bleomycin (Blenoxane)FDA LinkGeneric
12/2020 - 04/2013
7ImmunosorbentsIBA
09/2013 - 02/2003
6Transforming Growth Factors (Transforming Growth Factor)IBA
01/2018 - 01/2002
5AutoantibodiesIBA
08/2020 - 07/2002
5Adrenal Cortex Hormones (Corticosteroids)IBA
05/2018 - 10/2004
5Indicators and Reagents (Reagents)IBA
11/2017 - 02/2003
5Intravenous Immunoglobulins (IVIG)FDA Link
02/2017 - 01/2006
4Cell-Free Nucleic AcidsIBA
01/2022 - 09/2020
4Peptides (Polypeptides)IBA
02/2021 - 07/2004
4Biological ProductsIBA
12/2020 - 05/2014
4Collagen Type I (Type I Collagen)IBA
12/2020 - 02/2005
4LigandsIBA
05/2020 - 01/2016
4Infliximab (Remicade)FDA Link
01/2019 - 04/2016
4SteroidsIBA
02/2017 - 09/2008
4Tumor Biomarkers (Tumor Markers)IBA
01/2016 - 03/2011
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
06/2021 - 01/2015
3Interleukin-17 (Interleukin 17)IBA
02/2021 - 01/2012
3Adalimumab (Humira)FDA Link
01/2021 - 05/2018
3Transcription Factors (Transcription Factor)IBA
11/2020 - 01/2016
3Prednisolone (Predate)FDA LinkGeneric
11/2020 - 04/2009
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2020 - 01/2014
3Docetaxel (Taxotere)FDA Link
01/2020 - 02/2015
3SolutionsIBA
10/2018 - 01/2016
3Interleukin-6 (Interleukin 6)IBA
09/2018 - 05/2017
3InterferonsIBA
05/2018 - 01/2014
3Itraconazole (Sporanox)FDA LinkGeneric
01/2018 - 05/2011
3HLA Antigens (Human Leukocyte Antigens)IBA
01/2017 - 07/2004
3Silver Sulfadiazine (SSD)FDA LinkGeneric
10/2015 - 09/2013
3Angiopoietin-Like Protein 2IBA
02/2014 - 12/2011
3Interleukin-13IBA
03/2011 - 10/2004
3RNA (Ribonucleic Acid)IBA
03/2009 - 02/2003
3Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
06/2003 - 09/2002
2ParaffinIBA
02/2021 - 04/2010
2Small Interfering RNA (siRNA)IBA
11/2020 - 01/2015
2cadherin 5IBA
10/2020 - 08/2014
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2020 - 05/2006
2IpilimumabIBA
06/2020 - 12/2019
2C-Reactive ProteinIBA
01/2020 - 11/2018
2Anti-Bacterial Agents (Antibiotics)IBA
01/2019 - 11/2018
2Paclitaxel (Taxol)FDA LinkGeneric
01/2019 - 02/2015
2pembrolizumabIBA
01/2019 - 01/2017

Therapy/Procedure

31Therapeutics
07/2021 - 10/2004
11Immunotherapy
02/2021 - 04/2009
3Cell- and Tissue-Based Therapy (Cell Therapy)
05/2021 - 03/2016
3Drug Therapy (Chemotherapy)
04/2020 - 02/2015
3Combination Drug Therapy (Combination Chemotherapy)
01/2020 - 02/2015
3Skin Transplantation (Skin Grafting)
09/2016 - 04/2013
2Radiotherapy
05/2020 - 01/2019